Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

48.74
Delayed Data
As of Aug 18
 -0.55 / -1.12%
Today’s Change
37.38
Today|||52-Week Range
51.13
+26.89%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues5.3B5.3B6.3B6.6B
 
 
 
 
 
Cost of Goods Sold2.1B2.1B2.8B2.9B
 
 
 
 
 
Depreciation And Amortization340.0M319.0M774.0M648.0M
 
 
 
 
 
 
Operating ExpensesGross Income2.9B2.9B2.8B3.1B
 
 
 
 
 
General Expenses2.0B2.0B2.8B2.6B
 
 
 
 
 
Research And Development336.0M343.0M541.0M512.0M
 
 
 
 
 
Total Operating Expenses4.4B4.4B6.4B6.2B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income918.0M965.0M-66.0M455.0M
 
 
 
 
 
Extraordinary Charge-26.0M-6.0M-131.0M-26.0M
 
 
 
 
 
Interest Expense On Debt73.0M159.0M207.0M181.0M
 
 
 
 
 
Other Expenses-1.0B45.0M1.1B9.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-179.0M875.0M736.0M295.0M
 
 
 
 
 
Income Taxes-178.0M-110.0M-350.0M-25.0M
 
 
 
 
 
Discontinued Operations28.0M33.0M33.0M13.0M
 
 
 
 
 
Net Income-329.0M793.0M417.0M282.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.5B1.5B1.7B1.7B
 
 
 
 
 
Shares To Calculate EPS Diluted1.5B1.5B1.7B1.7B
 
 
 
 
 
 
Earnings Per ShareEPS-$0.22$0.53$0.24$0.16
 
 
 
 
 
EPS Diluted-$0.22$0.54$0.24$0.16